Support pathway for patients with ENT cancer
Support Pathway for ENT Cancer Patients in a Support Care Day Hospital Single-centre Prospective Randomised Interventional Study
NA · Clinique Pasteur Lanroze · NCT06512662
This study is testing whether a new, more complete support system for patients with ENT cancer before and after surgery can help reduce anxiety and improve their quality of life compared to standard care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Clinique Pasteur Lanroze (other) |
| Locations | 1 site (Brest) |
| Trial ID | NCT06512662 on ClinicalTrials.gov |
What this trial studies
This study aims to compare the standard pre-operative supportive care with a more comprehensive interdisciplinary care pathway for patients undergoing surgery for cancers of the upper respiratory and digestive tract. The focus is on reducing anxiety and improving the quality of life through additional post-operative day hospital consultations. By assessing the impact of these interventions, the study seeks to address the psychological, physical, and social challenges faced by patients during their treatment journey.
Who should consider this trial
Good fit: Ideal candidates are patients scheduled for surgery for VADS cancer who require at least one night of post-operative hospitalization and can understand French.
Not a fit: Patients with major cognitive disorders or significant anxiety disorders prior to cancer diagnosis may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce anxiety and enhance the quality of life for patients undergoing surgery for ENT cancers.
How similar studies have performed: While similar supportive care approaches have shown promise in improving patient outcomes, this specific intervention is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patient undergoing surgery for VADS cancer requiring at least one night's post-operative hospitalisation * Understanding of spoken and written French * Patient covered by a social security scheme Exclusion Criteria: * Protected patient under a protective measure or legal safeguard * Pregnant or breast-feeding patients * Patients suffering from major cognitive disorders * Patients with major anxiety disorders prior to the onset of cancer
Where this trial is running
Brest
- Clinique Pasteur Lanroze — Brest, France (RECRUITING)
Study contacts
- Study coordinator: Camille Vuarin, APN
- Email: cvuarin@chp-brest.bzh
- Phone: +33 2 98 34 20 31
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Otorhinolaryngologic Neoplasms, surgery, quality of life, anxiety, supportive care